๐ฐ Allakos News
Allakos News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Allakos. Real-time updates on events, politics, business and more.
February 6, 2024
Allakos Inc. (NASDAQ:ALLK – Get Free Report) has received a consensus rating of “Hold” from the seven research firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the company. The […]
January 17, 2024
Allakos (NASDAQ:ALLK – Get Free Report) was downgraded by Jefferies Financial Group from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Briefing.com reports. They presently have a $1.50 price target on the stock, down from their previous price target of $6.00. Jefferies Financial Group’s price […]
January 16, 2024
Allakosโs lirentelimab did not beat a placebo in separate Phase 2 tests in atopic dermatitis and spontaneous chronic urticaria. A restructuring now turns the biotechโs focus to an early-stage drug candidate also designed to treat inflammation.
December 18, 2023
Shares of Allakos Inc. (NASDAQ:ALLK – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the seven research firms that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating […]
December 17, 2023
Allakos Inc. (NASDAQ:ALLK – Get Free Report) was the target of a significant increase in short interest in the month of November. As of November 30th, there was short interest totalling 3,780,000 shares, an increase of 10.2% from the November 15th total of 3,430,000 shares. Based on an average trading volume of 1,010,000 shares, the […]
November 23, 2023
Allakos Inc. (NASDAQ:ALLK – Get Free Report) has been given an average rating of “Moderate Buy” by the seven analysts that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating on the company. The […]
September 11, 2023
Commodore Capital LP raised its position in Allakos Inc. (NASDAQ:ALLK – Free Report) by 15.6% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 1,900,000 shares of the company’s stock after acquiring an additional 256,500 shares during the period. Allakos makes up 1.3% of Commodore Capital LP’s investment […]
September 11, 2023
Logos Global Management LP lifted its stake in shares of Allakos Inc. (NASDAQ:ALLK – Free Report) by 4.7% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,536,666 shares of the company’s stock after buying an additional 250,000 shares during the quarter. Allakos comprises […]
August 15, 2023
Spherix Global Insights finds doctors have yet to define where APT-1011 will sit in the treatment path relative to EoE treatment gold standard, Dupixent....
August 1, 2023
Allakos (NASDAQ:ALLK – Get Free Report) is scheduled to be releasing its earnings data on Wednesday, August 2nd. Allakos (NASDAQ:ALLK – Get Free Report) last posted its earnings results on Tuesday, May 9th. The company reported ($0.49) earnings per share for the quarter, meeting the consensus estimate of ($0.49). On average, analysts expect Allakos to […]